Nu Skin Enterprises, Inc. : Navigating Growth Amid Challenges NUS is implementing growth initiatives focused on refreshing its market presence and entering high-growth sectors. The company is keen on introducing thoughtfully designed products that resonate with changing consumer demands. A notable launch is MYND360, a new series of clinically validated nutritional formulas aimed at enhancing cognitive health.

This new line includes six products meant to help users manage stress, improve focus, boost memory, and sleep better. MYND360 showcases Nu Skin’s dedication to the rapidly expanding brain health market. Despite these positive developments, along with the success of its Rhyz business, the company faces ongoing macroeconomic challenges.

Innovative Product Launches Fueling Growth

Nu Skin employs advanced technology and strategic product development to enhance its market share and sustain growth. The company’s long-term game plan is built on three foundational pillars: Products, Programs, and Platforms. Successful launches of innovative beauty devices have significantly contributed to its expansion.

In its second-quarter 2024 results, new products like ageLOC, WellSpa iO, and RenewSpa iO were key contributors, along with the company’s TRME weight management system. The ageLOC WellSpa iO has proven to be a valuable addition to its beauty device brands, receiving strong customer interest.

Image Source: Zacks Investment Research

The Rhyz Business: A Cornerstone for Nu Skin

Nu Skin’s Rhyz business is a central element of its growth strategy, demonstrating remarkable progress and contributing significantly to overall revenue. This venture creates a unified ecosystem combining consumer, technology, and manufacturing sectors, all focused on spearheading innovations in beauty, wellness, and lifestyle. Rhyz experienced a 32.3% revenue increase in the second quarter of 2024, making up 15% of total enterprise revenues, with expectations to grow to 20%-25% by 2025.

The success of Rhyz underscores Nu Skin’s ability to adapt to shifting consumer trends, particularly in influencer and affiliate marketing, both of which are projected to grow significantly. By enhancing Rhyz’s manufacturing capabilities and backing creator-led indie beauty brands, Nu Skin is strategically positioning itself for long-term growth in the beauty, wellness, and lifestyle sectors.

Current Challenges for Nu Skin

The second-quarter 2024 outcomes revealed that Nu Skin struggled with ongoing macroeconomic pressures that affected consumer spending, especially on premium products. These market headwinds, coupled with challenges in the direct selling sector and unfavorable foreign currency fluctuations, led to a 12.2% year-over-year decline in quarterly revenues to $439.1 million.

Nu Skin continues to navigate a tough operating environment primarily due to economic factors and pressures in the direct selling industry. Consequently, the management has revised their annual revenue guidance. They now expect revenues to fall in the range of $1.73-$1.81 billion for 2024, indicating a 12-8% decrease from the previous year’s figures. Previously, projections fluctuated between $1.73-$1.87 billion. The adjusted earnings per share forecast is lowered to 75-95 cents, which is down from the $1.85 adjusted earnings recorded in 2023. Initially, management projected adjusted EPS between 95 cents and $1.35 for 2024.

For the third quarter of 2024, revenues are anticipated to range between $430 million and $465 million, reflecting a decline of 14% to 7% compared to the same quarter last year. The expected adjusted EPS for the third quarter is estimated at 15-25 cents, down from 56 cents recorded in the same period last year. Over the past three months, Nu Skin’s shares have decreased 42.6%, while the industry has declined only 10%.

Outlook for Nu Skin

Nu Skin is making strides in growth through strategic initiatives, innovative product offerings, and its expanding Rhyz business. Despite these advances, the company confronts persistent challenges from macroeconomic pressures and direct selling industry headwinds. Moving forward, the company, holding a Zacks Rank of #3 (Hold), must find a balance between innovation and market realities to maintain its growth momentum.

Top Investment Picks

Inter Parfums IPAR specializes in manufacturing and distributing a diverse range of fragrances. The company currently has a Zacks Rank of 2 (Buy).

The Zacks Consensus Estimate for IPAR’s sales and earnings this financial year indicates increases of 10.2% and 8.4%, respectively, compared to the previous year. The company boasts a trailing four-quarter earnings surprise of approximately 2.5%.

Flowers Foods FLO is a major producer of packaged bakery goods in the United States and also carries a Zacks Rank of #2. FLO’s trailing four-quarter earnings surprise is roughly 1.9%.

The current financial-year sales and earnings estimates for Flowers Foods suggest growth of about 1% and 5%, respectively, from the prior reported figures.

McCormick & Company, Inc. MKC is a leading producer and distributor of spices, seasonings, and specialty foods, currently rated Zacks Rank #2.

The Zacks Consensus Estimate for McCormick’s sales and earnings indicates increases of 0.6% and 8.2%, respectively, compared to last year’s reported figures. The company has averaged a 13.8% surprise in earnings over the last four quarters.

To read this article on Zacks.com click here.